Now you see it, now you don’t
The Critical Role of Vapour Permeability Testing in Pharmaceutical Packaging Performance

Vapour permeability plays a decisive role in ensuring the safety, efficacy and commercial success of pharmaceutical products. As drug formulations become increasingly complex and sensitive, packaging performance is no longer secondary - it is fundamental to maintaining stability throughout shelf life. Versaperm, a technology leader in this field, provides advanced solutions to help manufacturers meet these demands with confidence.

Moisture and oxygen are among the primary causes of pharmaceutical degradation. Even minimal ingress of water vapour can trigger hydrolysis or physical instability, while oxygen exposure can lead to oxidation, reducing potency and compromising safety. Vapour permeability testing delivers the critical data needed to control these risks and design packaging systems that protect product integrity from manufacture to patient use.

However, pharmaceutical packaging is not simply about creating the highest possible barrier. Many products require a carefully controlled internal environment. While some demand extremely low moisture and oxygen levels, others depend on a defined equilibrium, where excessive dryness or complete isolation can destabilise the formulation. In certain applications, selective gas transmission is also necessary, for example to support sterilisation or maintain product functionality. Effective permeability testing is therefore essential both for minimising ingress and for precisely managing moisture and gas balance.

Versaperm’s advanced mass spectrometry-based vapour permeability measurement systems enable highly sensitive, rapid and accurate analysis of water vapour and a wide range of gases. This allows pharmaceutical companies to characterise packaging performance at a system level, improve design confidence, reduce the risk of failure or recall and optimise materials for both performance and sustainability.

By linking packaging performance directly to product quality, regulatory compliance and patient safety, Versaperm continues to support the pharmaceutical sector with measurement solutions that deliver clarity where it matters most.

ENDS

Please send any sales enquiries to
Versaperm Ltd: 10 Rawcliffe House, Howarth Road, Maidenhead, Berkshire, SL6 1AP, UK,
e.mail: info@versaperm.com Web: www.versaperm.com
UK Tel: +44 (01628) 777668
USA Tel +1 (617) 855-7477

For Further Press Information please contact:
Gerry Palmer @ the Palmer & Rose Partnership
Tel +44 (0) 1494 637499
e.mail gerry@palmer-rose.co.uk